People define "work" differently. For some, it's making useful objects that you can see and touch.
Joe Shields
Product Director, Enbrel, Wyeth
(JOHN HALPERN)
People define "work" differently. For some, it's making useful objects that you can see and touch. For others, it's closing a sale. As people rise in organizations, especially large ones, they need to continuously redefine what "work" is for them. It's also difficult to become comfortable with the unknown, giving up control and letting someone else possibly make mistakes. But if I'm really honest with myself, my mistakes have more to do with who I am today than my successes do. I believe that people must be tested to know what they are truly capable of. Some of the smartest and most dynamic people in business today work in healthcare marketing, and knowing this pushes me to keep up with them. Every day is a different challenge, and I feel that this industry has made me a better marketer and a more caring person.
Today, being a CEO is more sprint than marathon. Short-term expectations force decisions and actions at a pace we've never seen before. CEOs are given less time to demonstrate results, creating increased turnover and more opportunities for younger executives. In some ways, younger executives represent newfound optimism. A good question to ask candidates for a job is whether they see their biggest accomplishments ahead of them or behind them.
The pharmaceutical industry must reinvent itself to survive, and I plan to help drive some of the changes that are necessary. I cannot say what my job title will be in 10 years, but I imagine I will be at the intersection of innovation, technology, communications, and patient care. Appel CEO Steve Jobs said that one's choices make perfect sense only when looking backward. I think he's right.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.